EQUINE VETERINARY JOURNAL 发表证据以改善临床实践或扩展支持马兽医学的科学知识。这本无与伦比的国际科学期刊每年出版 6 次，包含同行评议的文章，其中包含原创的和潜在的重要发现。贡献来自世界各地的来源。

The Equine Veterinary Journal aims to publish evidence that improves clinical practice or expands the scientific knowledge supporting equine veterinary medicine. This unparalleled international scientific journal publishes six issues annually, featuring peer-reviewed articles that include original and potentially significant findings, with contributions from researchers around the world.

《Equine Veterinary Journal》致力于发表有助于改善临床实践或扩展马兽医学科学知识的证据。这本国际科学期刊每年出版六期，包含经过同行评审的文章，涵盖原创性和潜在的重要发现，贡献来自全球各地的研究者。

Equine Veterinary Journal

Abstract Background Noseband adjustment should avoid discomfort and allow some jaw movement. Objectives To determine pressure beneath a cavesson noseband at five tightness levels during standing and chewing. It was hypothesised that increased noseband tightness is associated with increases in nasal and mandibular pressures while standing and chewing, accompanied by increases in eye temperature and blink rate. Study design Experimental. Methods Eight highly‐trained dressage horses wore a snaffle bridle with their own bit. Pressure mats over the nasal bones and beneath the mandibular rami recorded sub‐noseband pressures (50 Hz) for five tightness levels (2.0, 1.5, 1.0, 0.5, 0.0 finger‐equivalents from loosest to tightest) measured using a taper gauge during quiet standing and chewing a treat. Eye temperature and blink rate were recorded synchronously. Data were analysed using Friedmans two‐way ANOVA with Wilcoxon post hoc tests and Bonferroni adjustment for repeated measures. Significance level p ≤ 0.01. Results During standing, total force increased from (mean ± SD) 5.8 ± 4.4 N (nasal) and 12.3 ± 8.2 N (mandibular) at 2.0 finger‐equivalents to 45.1 ± 24.9 N (nasal) and 70.7 ± 25.7 N (mandibular) at 0.0‐finger‐equivalents. Forces and pressures were higher on the mandibles than nasal bones although differences did not always reach statistical significance. Horses willingly ingested and chewed a treat at all noseband tightness levels generating forces ~100 N and pressure &gt;40 kPa without increases in eye temperature or blink rate that would suggest discomfort. Post hoc tests indicated significantly higher pressure for 0.0 finger‐equivalents than 2.0 finger‐equivalents ( p &lt; 0.01). Main limitations Small sample size. Nosebands always tested from loosest to tightest. Conclusions Mandibular pressure exceeded nasal pressure and values at both sites increased with noseband tightness. Horses accepted high noseband pressures when chewing a treat with a cavesson adjusted from 0.0 to 2.0 finger‐equivalents. Blink rate and eye temperature suggest horses were not distressed when chewing at 2.0 to 0.0 finger‐equivalents tightness.

Hilary M. Clayton

Rachel Murray

Jane M. Williams

Vicki Walker

Mark Fisher

Diane Fisher

Jane Nixon

Russell Mackechnie‐Guire

Facial pressure beneath a cavesson noseband adjusted to different tightness levels during standing and chewing

不同松紧度下站立和咀嚼时鼻革带对马面部压力的影响

Pablo R. Murcia

Thomas M. Chambers

Janet M. Daly

Nicola Pusterla

Batchuluun Damdinjav

Ulaankhuu Ankhanbaatar

Laura Mojsiejczuk

Equine Vet J

Should the equine community be concerned about the emergence of the <scp>H5N1</scp> subtype of highly pathogenic avian influenza in <scp>US</scp> cattle?

美国牛群中高致病性禽流感H5N1亚型的出现是否应引起马业界的关注？

Abstract Background The British horseracing industry is committed to reducing equine fatalities in jump racing. Race‐related fatalities are a major welfare concern and threaten the sport's social licence to operate. Objectives To describe the risk of, and determine risk factors for, fatality in British jump racing. Study design Retrospective cohort. Methods Analyses included all starts made in British jump races between January 2010 and April 2023. Available information for each horse, race, racecourse, trainer and jockey was collated and combined with details of all fatalities recorded by official veterinary officers in a central database. A fatality was defined as any post‐start veterinary event that resulted in the sudden death or euthanasia of a horse within 48 h of racing. Risk factors ( n = 101) were evaluated using mixed‐effects logistic regression. Data for steeplechase and hurdle starts were analysed separately. Results The overall fatality rate was 5.9 per 1000 steeplechase starts ( n = 836/141 922; 95% CI 5.5–6.3) and 4.5 per 1000 hurdle starts ( n = 1096/242 486; 95% CI 4.3–4.8). In both race types, fallers (steeplechase: OR 28.7, 95% CI 23.0–35.8; hurdle: OR 41.4, 95% CI 32.9–52.0) and older horses (steeplechase: OR 1.1 per extra year, 95% CI 1.1–1.2; hurdle: OR 1.2 per extra year, 95% CI 1.1–1.2) had higher odds of fatality. In steeplechase racing, starts made in summer (OR 1.2, 95% CI 1.0–1.5) and by non‐GB trained horses (OR 2.0, 95% CI 1.4–3.0) experienced higher fatality odds. In hurdling, maiden races (OR 1.3, 95% CI 1.0–1.6) were at higher odds of fatality. In both race types, softer going decreased the odds of fatality. Approximately half of the unexplained variation in fatality odds was attributable to horse. Main limitations Analysis was restricted to routinely recorded race‐day factors and performance history. Conclusions Reducing the risk of falling and racing on softer ground could substantially decrease fatalities in jump racing.

Sarah E. Allen

Sally Taylor

James Given

Kristien L. Verheyen

Risk factors for fatality in jump racing <scp>Thoroughbreds</scp> in <scp>Great Britain</scp> (2010–2023)

英国（2010-2023年）跳跃赛马中纯种马死亡风险因素

Victoria Anne Colgate

<scp>IFHA Global Summit</scp> on <scp>Equine Safety</scp> and <scp>Technology</scp>: Reducing the risk of <scp>Exercise Associated Sudden Death</scp>

IFHA 全球峰会：关于马匹安全和技术的讨论：减少运动相关猝死的风险

Abstract Background Post‐anaesthetic sedation is administered to horses to improve recovery quality from inhalant anaesthesia and reduce the risk of catastrophic injury. A single dose of dexmedetomidine for this purpose has not been evaluated clinically. Objectives To determine whether dexmedetomidine improves recovery quality from sevoflurane anaesthesia compared to a previously studied dose of romifidine. Study design Prospective, randomised, masked clinical trial. Methods Ninety‐nine, adult, client‐owned horses anaesthetised for elective procedures completed the trial. Anaesthetic protocol was standardised. Horses were randomly assigned to receive either dexmedetomidine 1 mcg/kg bwt (D) or romifidine 20 mcg/kg bwt (R) intravenously at their first spontaneous breath in recovery. Recoveries were reviewed and independently assigned subjective visual analogue scale (VAS) scores (0‐100 mm, worst to best) for overall quality and standing ataxia scores (1‐4, none to severe) by two anaesthesiologists blinded to treatment group. Objective anaesthesia and recovery data were also recorded. Comparisons were made using the Chi‐square, Wilcoxon rank sum, linear models or Welch‐Satterthwaite two‐sample t ‐test ( P ≤ .05). Predictors of VAS score were analysed independent of treatment group. Results There were no significant differences between groups except end‐tidal sevoflurane (FE´Sevo) concentration and post‐induction extra ketamine dosing. Including FE´Sevo and additional ketamine in the analysis as covariates, VAS scores and time to standing were not significantly different between groups. Increased age, not receiving a nerve block, increased duration of hypotension, and having a nervous temperament were significant predictors of VAS score. Main limitations No universal recovery scale exists for inter‐study comparisons. Conclusions After sevoflurane anaesthesia, sedation with dexmedetomidine or romifidine provides clinically similar recovery time and quality.

Rachel C. Hector

Marlis L. Rezende

Khursheed R. Mama

Ann M. Hess

Recovery quality following a single post‐anaesthetic dose of dexmedetomidine or romifidine in sevoflurane anaesthetised horses

七氟烷麻醉马匹单次使用右美托咪定或罗米非定后的恢复质量

Abstract Background Desmotomy of the accessory ligament of the superficial digital flexor tendon (AL‐SDFT) has been described for the treatment of superficial digital flexor tendon (SDFT) tendinopathy in Thoroughbred and Standardbred racehorses, and in event horses. To our knowledge, the outcome of this procedure has not been described in a population of warmblood horses. Objective To report on the outcome of treatment of SDFT tendinopathy in warmblood horses using tenoscopic desmotomy of the main part of the AL‐SDFT. Study design Prospective observational case series. Methods All 62 horses included in the case series had uni‐ or bilateral SDFT tendinopathy within the metacarpal/carpal region. The following data were collected and analysed using crosstabulations: breed, age, sex, use, affected limb(s), duration of tendinopathy, lameness grade, type and size of the SDFT lesion, bi‐ or unilateral desmotomy, duration of surgery, intraoperative findings, intraoperative/post‐operative complications, duration of hospitalisation and outcome 24 months after surgery. Results Forty‐six horses (75%) were sound with 31 (51%) of these horses performing at the same level as prior to injury. Recurrent SDFT injuries or persistent lameness was observed in 15 (25%) horses. Two horses (3%) developed septic tenosynovitis post‐operatively, one required euthanasia. Horses with lesions in the proximal third of the SDFT had a better outcome than those with lesions in the two distal thirds (OR = 4.71, 95% CI = 1.33–16.70). Main Limitations There were no control groups of horses with SDFT tendinopathy treated by conservative therapy, tenoscopic complete or conventional open desmotomy. Conclusions Tenoscopic desmotomy of the main part of the AL‐SDFT is a successful treatment for SDFT tendinopathy in warmblood horses, especially in proximal SDFT lesions.

Marlis Blatter

Hannah‐Sophie Chapman

Monika Heinzel‐Gutenbrunner

Guido von Plato

Astrid Rijkenhuizen

Performance of Warmblood horses following tenoscopic desmotomy of the main part of the accessory ligament of the superficial digital flexor tendon for treatment of tendinopathy: 62 cases

用于治疗腱病的浅屈肌腱副韧带主部经内窥镜切断术后温血马的表现：62例病例

Abbreviation	Equine Vet. J.
Journal Impact	2.56
Quartiles(Global)	VETERINARY SCIENCES(Q1)

ISSN	0425-1644, 2042-3306
h-index	100

Publication Information	Publisher: Wiley-Blackwell，Publishing cycle: Bimonthly，Journal Type: journal，Open Access Journals: No
Basic data	Year of publication: 1968，Proportion of original research papers: 90.22%，Self Citation Rate:20.80%， Gold OA Rate: 44.00%
Average review cycle	网友分享经验：一般,6-16周
Average recruitment ratio	网友分享经验：较易

Equine Veterinary Journal

Journal Citation Format

A journal article with 1 author

A journal article with 2 authors

A journal article with 3 authors

A journal article with 5 or more authors

Books Citation Format

Thesis Citation Format

Web sites Citation Format

Patent Citation Format

Staying up late manually editing references? ivySCI automatically matches journals and helps you generate references with a single click.

Share Submission Experience

Facial pressure beneath a cavesson noseband adjusted to different tightness levels during standing and chewing

Should the equine community be concerned about the emergence of the H5N1 subtype of highly pathogenic avian influenza in US cattle?

Risk factors for fatality in jump racing Thoroughbreds in Great Britain (2010–2023)

IFHA Global Summit on Equine Safety and Technology: Reducing the risk of Exercise Associated Sudden Death

Recovery quality following a single post‐anaesthetic dose of dexmedetomidine or romifidine in sevoflurane anaesthetised horses

Facial pressure beneath a cavesson noseband adjusted to different tightness levels during standing and chewing

Risk factors for fatality in jump racing Thoroughbreds in Great Britain (2010–2023)

IFHA Global Summit on Equine Safety and Technology: Reducing the risk of Exercise Associated Sudden Death

Should the equine community be concerned about the emergence of the H5N1 subtype of highly pathogenic avian influenza in US cattle?

Performance of Warmblood horses following tenoscopic desmotomy of the main part of the accessory ligament of the superficial digital flexor tendon for treatment of tendinopathy: 62 cases